HemaQuest Pharmaceuticals

• Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders

  Phase 2, Terminated, 1 person, Oct 9, 2009

• Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

  Phase 2, Terminated, 1 person, Jun 10, 2009

Sources: clinicaltrials.gov